Evidence map›Paper›PMID 39625215›Full record

ReviewTherapeutic advances in cardiovascular disease

Enhancing coronary artery plaque analysis via artificial intelligence-driven cardiovascular computed tomography.

Jeffrey Xia, Kinan Bachour, Abdul-Rahman M Suleiman, Jacob S Roberts, Sammy Sayed, Geoffrey W Cho

Abstract readReview
In one paragraph

Review in Therapeutic advances in cardiovascular disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. First scan, then treat: 10 years of the SCOT-HEART study.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  5. Article
  6. Review
  7. Trading off Iodine and Radiation Dose in Coronary Computed Tomography.Journal of cardiovascular development and disease · 2025
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jeffrey XiaDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Kinan BachourDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Abdul-Rahman M SuleimanDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Jacob S RobertsDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Sammy SayedDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Geoffrey W ChoDavid Geffen School of Medicine at UCLA, 100 Medical Plaza, Suite 545, Los Angeles, CA 90024, USA.ORCID 0000-0002-4438-2093

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary computed tomography angiography (CCTA) is a noninvasive imaging modality of cardiac structures and vasculature considered comparable to invasive coronary angiography for the evaluation of coronary artery disease (CAD) in several major cardiovascular guidelines. Conventional image acquisition, processing, and analysis of CCTA imaging have progressed significantly in the past decade through advances in technology, computation, and engineering. However, the advent of artificial intelligence (AI)-driven analysis of CCTA further drives past the limitations of conventional CCTA, allowing for greater achievements in speed, consistency, accuracy, and safety. AI-driven CCTA (AI-CCTA) has achieved a significant reduction in radiation exposure for patients, allowing for high-quality scans with sub-millisievert radiation doses. AI-CCTA has demonstrated comparable accuracy and consistency in manual coronary artery calcium scoring against expert human readers. An advantage over invasive coronary angiography, which provides luminal information only, CCTA allows for plaque characterization, providing detailed information on the quality of plaque and offering further prognosticative value for the management of CAD. Combined with AI, many recent studies demonstrate the efficacy, accuracy, efficiency, and precision of AI-driven analysis of CCTA imaging for the evaluation of CAD, including assessing degree stenosis, adverse plaque characteristics, and CT fractional flow reserve. The limitations of AI-CCTA include its early phase in investigation, the need for further improvements in AI modeling, possible medicolegal implications, and the need for further large-scale validation studies. Despite these limitations, AI-CCTA represents an important opportunity for improving cardiovascular care in an increasingly advanced and data-driven world of modern medicine.

Indexed as

Artificial IntelligenceComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary VesselsPlaque, AtheroscleroticPredictive Value of TestsRadiographic Image Interpretation, Computer-AssistedHumansPrognosisReproducibility of ResultsSeverity of Illness IndexAPCartificial intelligenceCACCADCCTACONFIRMDLFFT-CTML

Identifiers

PMID39625215
PMCPMC11615974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.